
Breast Cancer Risk Reduction Options: Preventive Medication, Risk-Reducing Mastectomy, and Who Should Consider Them
People at higher-than-average breast cancer risk have several levels of risk-reducing options: lifestyle changes, enhanced screening, risk-reducing medication (chemoprevention), which can roughly halve risk, and risk-reducing mastectomy, which lowers risk by more than 90% in BRCA carriers. The right choice depends on risk level, age and personal preference. At Namarak Hospital, breast surgeons assess risk and provide genetic counseling in-house, and can perform nipple-sparing mastectomy with immediate reconstruction for those who choose preventive surgery.
Who is at high risk?
Carriers of gene mutations such as BRCA1, BRCA2, PALB2 or TP53 — see BRCA genes and family history
Several relatives with breast or ovarian cancer, or cancer at a young age
Previous high-risk lesions such as ADH, ALH or LCIS — see High-risk breast lesions
Chest radiation before age 30
High risk on models such as Tyrer–Cuzick (IBIS): lifetime risk of 20% or more, or high 5-year risk
1. Lifestyle (for everyone)
Weight control, especially after menopause
Regular exercise
Limit or avoid alcohol
Breastfeed when possible
Use menopausal hormone therapy only as needed — see Risk factors and prevention
2. Enhanced screening
High-risk people start screening earlier and more often, such as yearly MRI with mammography for BRCA carriers; under the Thai guideline, mammography with ultrasound may be alternated with MRI. Screening finds cancer early but does not lower the chance of developing it — see Breast MRI
3. Risk-reducing medication (chemoprevention)
Tamoxifen 20 mg for 5 years — lowers the risk of hormone receptor-positive cancer by about 30–50%, before or after menopause; key side effects are blood clots and, rarely, uterine cancer — see Tamoxifen side effects
Low-dose tamoxifen 5 mg for 3 years — the TAM-01 trial roughly halved new cancers in people with ADH, LCIS or DCIS, with fewer side effects
Raloxifene — for postmenopausal women, with fewer clots and uterine effects than tamoxifen
Aromatase inhibitors (anastrozole, exemestane) — for postmenopausal women, roughly halving risk (IBIS-II, MAP.3); bone health needs attention — see Aromatase inhibitors and bone health
The USPSTF recommends offering risk-reducing medication to women at increased risk and low risk of side effects, but not to women at average risk
4. Risk-reducing surgery
Bilateral risk-reducing mastectomy
Lowers breast cancer risk by more than 90% in BRCA1/BRCA2 carriers
Can be nipple-sparing with immediate reconstruction for a natural appearance — see Nipple-sparing mastectomy
Not recommended for average-risk people or for anxiety alone
Downsides include reduced skin and nipple sensation and reconstruction complications; allow enough counseling and time to decide
Risk-reducing salpingo-oophorectomy
Recommended for BRCA1 carriers at 35–40 and BRCA2 carriers at 40–45, after childbearing is complete
Greatly lowers ovarian cancer risk and overall mortality
Planned together with a specialist gynecologist
How to choose
The decision depends on risk level, age, family plans, acceptable side effects and personal feelings; there is no single right answer. Discuss options with a breast surgeon and seek genetic counseling — see Multigene panel genetic testing
Frequently asked questions (FAQ)
How effective is preventive medication?
Tamoxifen, raloxifene and aromatase inhibitors lower the risk of hormone receptor-positive breast cancer by about 30–50%, and suit high-risk people with low risk of side effects.
Do all BRCA carriers need a mastectomy?
No. It is one option that lowers risk by more than 90%; another is enhanced screening with MRI and mammography. The decision is individual.
Can cancer still develop after preventive mastectomy?
A small risk remains because not every cell of breast tissue can be removed, but risk falls by more than 90%.
Can the nipple be preserved in preventive mastectomy?
In most people, yes. Nipple-sparing mastectomy with immediate reconstruction gives a natural appearance.
Who should have a breast cancer risk assessment?
People with a family history of breast or ovarian cancer, previous high-risk lesions, or chest radiation at a young age should consult a breast surgeon for assessment and planning.
About Namarak Hospital
Namarak Hospital is a specialized breast and breast cancer hospital in Bangkok, providing complete care in one place — from diagnosis with 3D mammography, ultrasound, automated breast ultrasound (ABUS) and biopsy to comprehensive breast cancer treatment, including breast-conserving and reconstructive surgery, intraoperative radiotherapy (IORT), chemotherapy, targeted therapy and endocrine therapy, planned by a multidisciplinary team according to the latest international guidelines. See Breast cancer treatment: a complete guide, contact us on LINE, tel. +66 2 059 0245, or our Second Opinion service.
Related articles
References
US Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: Recommendation Statement. JAMA 2019;322:857–67
Visvanathan K, et al. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. J Clin Oncol 2019;37:3152–65
Cuzick J, et al. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results. Lancet 2020;395:117–22
DeCensi A, et al. Low-Dose Tamoxifen (TAM-01). J Clin Oncol 2019;37:1629–37
Tung NM, et al. Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline. J Clin Oncol 2020;38:2080–106
NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction; Genetic/Familial High-Risk Assessment, 2026
Medically reviewed by: Namarak Hospital medical team · Last checked: 17 November 2026 · This information is for general education and is not individual medical advice. Please consult your doctor for diagnosis and treatment suited to you.





Comments